Prognostic Impact of Tumor Growth Rate During Second-line Chemotherapy in Patients With Gastric Cancer
Based on the absence of significant differences in survival outcomes between the high and low TGR groups, sequential late-line chemotherapy might be considered important, even for patients with high TGR.
Authors
- Kiyoshi Maeda (ORCID: https://orcid.org/0000-0002-5138-4767)
- Takahiro Toyokawa
- Shigeru Lee (ORCID: https://orcid.org/0009-0008-5610-864X)
- Yuichiro Miki (ORCID: https://orcid.org/0000-0003-0116-0922)
- Hiroaki Tanaka (ORCID: https://orcid.org/0000-0001-8814-740X)
- Mami Yoshii
- Tatsuro Tamura
Institutions
- Fuchu Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21873/cdp.10380
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00